Gene therapy for respiratory disorders requires stable gene transfer to epithelial progenitor cells, efficient engraftment of these genetically modified progenitors in the respiratory epithelium and regulated transgene expression in differentiated progeny of these cells. Recently, cells have been identified in marrow that can contribute to tissue repair and regeneration in hematopoietic and non-hematopoietic tissues. In preliminary studies by our group, transgene expressing donor epithelial cells were detected in the lung following transplantation of retrovirally transduced bone marrow into murine recipients. At 2-5 months post-transplant, -1% of cytokeratin positive epithelial cells were EGFP transgene positive donor cells. Based on these data our overall hypothesis is that stem cells and their progeny can engraft in the respiratory epithelium and contribute to alveolar epithelial layer maintenance and regeneration. In studies undertaken in our currently funded grant, we are characterizing the stem cells in marrow capable of contributing to alveolar epithelium. In the proposed study, we will investigate another source of stem cells, embryonic stem cells, to differentiate into respiratory epithelium. This study has the following specific aims: 1) Maintain three HES cell lines (WA01, WA09 and UC06) in vitro in an undifferentiated state. 2) Investigate the conditions which induce HES cells to differentiate into respiratory epithelium. The technical expertise and information gained in these studies will facilitate the development of a program to study human embryonic stem cell culture and controlled respiratory differentiation. The overall goal of these studies is to further our understanding of the biology of human embryonic stem cells, and their potential to serve as vehicles for therapeutic cell delivery to the respiratory epithelium. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
3R21HL072211-03S1
Application #
6858957
Study Section
Special Emphasis Panel (ZRG1-BDA-F (50))
Program Officer
Berberich, Mary Anne
Project Start
2002-09-11
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
3
Fiscal Year
2004
Total Cost
$74,400
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
052277936
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Janczewski, Wiktor A; Tashima, Alexis; Hsu, Paul et al. (2013) Role of inhibition in respiratory pattern generation. J Neurosci 33:5454-65
Hendrickson, Benjamin; Senadheera, Dinithi; Mishra, Suparna et al. (2007) Development of lentiviral vectors with regulated respiratory epithelial expression in vivo. Am J Respir Cell Mol Biol 37:414-23
Lee, Jooeun; Reddy, Raghava; Barsky, Lora et al. (2006) Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. Am J Physiol Lung Cell Mol Physiol 290:L685-L694
Tarantal, Alice F; McDonald, Ruth J; Jimenez, Daniel F et al. (2005) Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery. Mol Ther 12:87-98